We’ve joined the Health Research Authority, the National Institute for Health and Care Research, and a host of organisations ...

For further information on the guideline development process, please see how we develop NICE guidelines ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Teclistamab for treating relapsed and refractory multiple myeloma after 3 or more treatments TA1015 13 November 2024 13 November 2024 ...

Balloon disimpaction of the baby's head at emergency caesarean during the second stage of labour Interventional procedure consultation Interventional procedures guidance 19 December 2024 Digital ...

These tools set cookies that store anonymised information about how you got to the site, and how you interact with the site.

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

It recommends healthcare practitioners should offer a low-dose combination of inhaled corticosteroids (ICS) and formoterol to be taken as needed for everyone aged 12 and over with newly diagnosed ...

This summary report is based on the NICE assumptions used in the resource impact template. Users can amend the 'Inputs and eligible population' and 'Unit costs' worksheets in the template to reflect ...

This guideline covers diagnosing, monitoring and managing asthma in adults, young people and children. It aims to improve the accuracy of diagnosis, help people to control their asthma and reduce the ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.